Alzheimer's disease

Biogen CEO sees progress in launch of Alzheimer’s drug Leqembi
BioPharma Dive
Mon, 01/8/24 - 10:22 pm
Biogen
Pharma CEOs
Chris Viehbacher
Leqembi
Alzheimer's disease
insurance
JPMHC 2024
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
CP Wire
Wed, 11/22/23 - 12:46 pm
Alzheimer's disease
simulation
drug discovery
SIAM News
Duke University
Penn State University
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Wed, 11/22/23 - 12:17 pm
Alzheimer's disease
simulation
drug discovery
SIAM News
Duke University
Penn State University
A year after Roche's Alzheimer's failure, scientists reflect on what could have been
Fierce Biotech
Wed, 11/15/23 - 11:49 pm
Roche
Genentech
Alzheimer's disease
gantenerumab
Biogen's M&A, Alzheimer's drug launch costs spark profit forecast cut
Reuters
Wed, 11/8/23 - 11:35 am
Biogen
Alzheimer's disease
Leqembi
Reata
M&A
earnings
Eisai expects Alzheimer's drug to rake in revenue of $66.5 million by March
Reuters
Tue, 11/7/23 - 09:57 am
Eisai
Leqembi
Alzheimer's disease
Co-developer of Cassava’s potential Alzheimer’s drug cited for ‘egregious misconduct’
Science
Mon, 10/30/23 - 08:15 pm
Cassava Sciences
Alzheimer's disease
Simulfilam
clinical trials
Doubts abound about a new Alzheimer’s blood test
Medical Marketing and Media
Fri, 10/27/23 - 11:31 am
diagnostics
Quest Diagnostics
Medtech
Alzheimer's disease
AD-Detect
Merck terminates Phase II trials for Alzheimer’s drug due to liver toxicity
Clinical Trials Arena
Thu, 10/26/23 - 11:53 am
Merck
clinical trials
MK-1942
liver toxicity
Alzheimer's disease
Eisai says new data could support more convenient form of Alzheimer’s drug Leqembi
BioPharma Dive
Wed, 10/25/23 - 10:42 pm
Eisai
Biogen
Leqembi
Alzheimer's disease
Araclon vaccine appears to slow Alzheimer's in exploratory phase 2 analysis, spurring review of next steps
Fierce Biotech
Wed, 10/25/23 - 09:56 am
Araclon
Grifols
Alzheimer's disease
clinical trials
vaccines
ABvac40
CuraSen to bring new Alzheimer’s drug into trial in 2024
Clinical Trials Arena
Wed, 10/18/23 - 10:05 am
CuraSen Therapeutics
clinical trials
CST-3056
Alzheimer's disease
As 'harvest time' arrives for Alzheimer's, neuroscientist reflects on next steps for drug development
Fierce Biotech
Mon, 10/16/23 - 10:12 am
Alzheimer's disease
Biogen
Eisai
Eli Lilly
Leqembi
donanemab
Biogen's Aduhelm headache returns as appeals court revives part of investor lawsuit
Fierce Pharma
Thu, 10/12/23 - 05:18 pm
Biogen
Aduhelm
legal
Eisai
Alzheimer's disease
Labcorp launches 3-part blood test for Alzheimer's
Reuters
Wed, 10/11/23 - 10:02 am
LabCorp
Medtech
diagnostics
biomarkers
Alzheimer's disease
Novartis-backed AstronauTx heads off for Alzheimer's mission with $61M series A
Fierce Biotech
Mon, 10/9/23 - 11:12 am
AstronauTx
Novartis
Alzheimer's disease
Longeveron's Alzheimer's Candidate Meets Safety Goal In Mid-Stage Study
Benzinga
Fri, 10/6/23 - 11:45 am
Longeveron
clinical trials
Alzheimer's disease
lomacel-B
Roche pays Ionis $60M upfront to license RNA-targeting Alzheimer's, Huntington's programs
Fierce Biotech
Wed, 09/27/23 - 10:14 am
Roche
Ionis Pharmaceuticals
RNA
Alzheimer's disease
Huntington's disease
Japan approves Alzheimer's treatment Leqembi by Eisai and Biogen
Reuters
Tue, 09/26/23 - 10:23 am
Biogen
Eisai
Japan
Leqembi
Alzheimer's disease
Cassava Sciences Announces Positive Interim Safety Review of Simufilam On-going Phase 3 Trials in Patients with Alzheimer’s Disease
BioSpace
Mon, 09/18/23 - 07:45 pm
Cassava Sciences
clinical trials
Simulfilam
Alzheimer's disease

Pages